Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000319690 | SCV000338488 | uncertain significance | not provided | 2016-01-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000541005 | SCV000638179 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2F | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000319690 | SCV000973221 | likely benign | not provided | 2018-06-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002401990 | SCV002674241 | likely benign | Inborn genetic diseases | 2020-03-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |